Research-driven. Technology-enabled.
AlynaMOM is an early-stage initiative focused on developing AI-assisted tools for breast cancer research.
We are investigating how modern language models, neural networks, and computational methods can support scientific information analysis and the exploration of complex biomedical questions.
Our long-term objective is to build a dedicated research platform that helps make scientific information more accessible and research workflows more efficient.
Our Mission
“To contribute to the advancement of breast cancer research by exploring responsible applications of artificial intelligence.”
Our Vision
“To build a specialized biomedical research platform that helps researchers investigate complex scientific questions more efficiently.”
Development Stage
“AlynaMOM is currently conducting internal development and testing. The platform is not yet publicly available.”
Founder
Kylian Corson
Founder · AlynaMOM
Kylian Corson founded AlynaMOM to explore how advanced computational language models and neural architectures can be applied responsibly to support scientific workflows in oncology.
Guided by the conviction that biomedical tools must prioritize epistemic rigor over marketing sensationalism, the initiative is being built step-by-step through careful computational prototyping, literature indexing, and direct dialogue with biomedical researchers.
What AlynaMOM is — and what it is not.
Biomedical Research Technology: AlynaMOM is an independent technology initiative focused on computational tools to accelerate scientific literature analysis and hypothesis exploration for oncology researchers.
Not a Consumer Health Service: AlynaMOM is not a consumer diagnosis app, does not provide medical consultations, does not process direct patient diagnostics, and is not a clinical healthcare provider.
Not a Marketing Agency: We do not offer generic AI consulting, corporate marketing services, or speculative financial advice.
AI as a research tool, not a substitute for medical judgment.
AlynaMOM is developing technology intended to support biomedical research. Its objective is to explore how artificial intelligence can assist with scientific information processing, literature analysis, and research hypothesis development.
AlynaMOM does not currently provide medical diagnosis, treatment recommendations, patient-specific clinical advice, or emergency medical services through this website.
AI-generated information may be incomplete, inaccurate, or misleading and must not be treated as independently validated scientific evidence.
Any future biomedical research application will require appropriate expert review, validation, and safeguards before being used in relevant research settings.
Interested in scientific dialogue or technical collaboration?
Direct inquiries: contact@alynamom.fr